[Suppressive antibiotic treatment with dalbavancin. A case report]. [PDF]
Rev Esp Quimioter, 2021 Barbero Allende JM +3 more
europepmc +1 more source
Formas farmacéuticas sólidas destinadas a la bioterapia con microorganismos probióticos
, 2018 Programa Oficial de Doctorado en ...
openaire +1 more source
A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation. [PDF]
J Exp Clin Cancer Res, 2021 Maio M +7 more
europepmc +1 more source
The Italian Network for Tumor Bio-Immunotherapy (NIBIT) Foundation: ongoing and prospective activities in immuno-oncology. [PDF]
Cancer Immunol Immunother, 2019 Di Giacomo AM +6 more
europepmc +1 more source
Defective HLA class I antigen processing machinery in cancer. [PDF]
Cancer Immunol Immunother, 2018 Cai L +7 more
europepmc +1 more source
[Diagnostic protocol and empirical treatment in emergency department of respiratory infections]. [PDF]
Medicine (Baltimore), 2018 Graziani Noriega D, Ampuero López A.
europepmc +1 more source
The non-small cell lung cancer immune landscape: emerging complexity, prognostic relevance and prospective significance in the context of immunotherapy. [PDF]
Cancer Immunol Immunother, 2018 Anichini A +3 more
europepmc +1 more source
[Prevalence and risk factors for methicillin-resistant Staphylococcus aureus infection in children]. [PDF]
Rev Esp QuimioterMarín Oliván P +7 more
europepmc +1 more source
Somatically mutated tumor antigens in the quest for a more efficacious patient-oriented immunotherapy of cancer. [PDF]
Cancer Immunol Immunother, 2015 Trajanoski Z +5 more
europepmc +1 more source
CTLA4 blockade in mesothelioma: finally a competing strategy over cytotoxic/target therapy? [PDF]
Cancer Immunol Immunother, 2015 Calabrò L +6 more
europepmc +1 more source